Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A(TW:1762)
NT$32.75+1.70 (+5.48%)
TW:1762
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A financials statements
NT$32.75
At close:+1.70 (+5.48%)
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A (1762) Income Statement
Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A Income Statement
Last quarter (Q2 2026), Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A's total revenue was NT$305.18M, a decrease of 11.29% from the same quarter last year. In Q2, Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A's net income was NT$41.53M. See Chunghwa Chemical Synthesis & Biotech Co., Ltd. Class A’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 804.88M | NT$ 1.35B | NT$ 2.09B | NT$ 2.12B | NT$ 1.93B | |
| NT$ -8.86M | NT$ 394.32M | NT$ 757.31M | NT$ 961.76M | NT$ 949.39M | |
| NT$ 310.67M | NT$ 387.98M | NT$ 757.31M | NT$ 516.57M | NT$ 492.57M | |
| Depreciation and Amortization | NT$ 191.35M | NT$ 199.16M | NT$ 193.00M | NT$ 169.05M | NT$ 131.99M |
| NT$ -47.60M | NT$ 277.66M | NT$ 545.93M | NT$ 743.72M | NT$ 651.27M | |
| NT$ -319.54M | NT$ 6.34M | NT$ 280.81M | NT$ 574.67M | NT$ 519.28M | |
| NT$ 63.86M | NT$ 50.88M | NT$ 52.68M | NT$ 119.77M | NT$ 59.14M | |
| NT$ -255.68M | NT$ 57.22M | NT$ 333.49M | NT$ 583.30M | NT$ 497.61M | |
| NT$ -243.85M | NT$ 53.03M | NT$ 264.91M | NT$ 465.87M | NT$ 400.78M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -4.39 | NT$ 0.70 | NT$ 3.42 | NT$ 6.01 | NT$ 5.17 |
| Diluted EPS | NT$ -4.39 | NT$ 0.94 | NT$ 3.39 | NT$ 5.93 | NT$ 5.12 |
| Weighted Average Shares Outstanding | 55.55M | 76.23M | 77.46M | 77.56M | 77.56M |
| Weighted Average Shares Outstanding (Diluted) | 55.55M | 76.23M | 78.09M | 78.50M | 78.32M |
Currency in TWD
